Patent eligibility challenges under 35 U.S.C. §101 have been effective tools for defendants to obtain early dismissal of a case without extensive fact finding since the Supreme Court ruling in Alice.

The U.S. Court of Appeals for the Federal Circuit recently decided an appeal of a patent lawsuit involving Cardionet LLC, of Conshohocken, Pa., invalidating the Cardionet patent for lack of subject ...

In CardioNet, LLC v. InfoBionic, Inc., the Federal Circuit found that the medical device claims at issue were “directed to” patent-eligible subject matter under 35 USC § 101. The district court had ...

The U.S. Court of Appeals for the Federal Circuit on Wednesday narrowed a patent dispute between rivals in the market for cardiac telemetry devices, saying patents owned by CardioNet LLC were invalid.

Attorneys at Hall Booth Smith on Monday removed a wrongful death action against CardioNet LLC to Tennessee Western District Court. The suit was filed by Rosenblum & Reisman on behalf of Suzanne ...

Cardiac monitoring firms to pay more than $44 million to resolve allegations of false claims act violations -U.S. BioTelemetry Inc. and its subsidiary CardioNet LLC have agreed to pay $44.9 million to ...